Blogs

blog_1.jpg

ToxSci December 2024 Issue Available

By Cynthia Rider posted 12-05-2024 10:47 AM

  

The December 2024 issue of Toxicological Sciences includes an Editoral that thanks the volunteer service of experts who conducted peer reviews for ToxSci in 2024. A Contemporary Review covers epidemiological, animal, and cell studies on PM2.5 exposure and bone health, as well as studies on PM2.5-induced diseases with skeletal complications, while an In-Depth Review centers on the evolution of RAS inhibitors in cancer therapy, delving into the common adverse effects associated with these inhibitors, their underlying mechanisms, and the potential strategies for mitigation. Additionally, two #ToxSpotlight articles are featured: One highlights a pharmacokinetic analysis of nicotine and its metabolites in male Sprague-Dawley rats following nose-only inhalation, oral gavage, and intravenous infusion of nicotine while the other discusses the hemolytic toxicity tapestry of peptides using chemical space complex networks.

Other papers in the December 2024 issue (sorted by topic category) are:

Carcinogenesis
Urinary Bladder Carcinogenic Potential of 4,40-methylenebis(2-chloroaniline) in Humanized-Liver Mice

Genetic and Epigenetic Toxicology
Comprehensive Genotoxicity and Carcinogenicity Assessment of Molnupiravir (open access)

Remember that electronic access to ToxSci articles is a benefit for Full and Associate members—use your SOT credentials to log in and view ToxSci articles. Other membership types can request discounted access to ToxSci at any time.


#ToxicologicalSciences

0 comments
5 views